Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,031Revenue (TTM) $M320Net Margin (%)-5.6Altman Z-Score12.9
Enterprise Value $M948EPS (TTM) $-0.5Operating Margin %-6.3Piotroski F-Score7
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-5.7Higher ROA y-yY
Price/Book7.210-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio3.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-9.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-13.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.5ROIC % (ttm)-45.2Gross Margin Increase y-yY

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 30.818%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 30.812%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 30.8132%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 30.8174%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cole G BradleyCOO 2016-12-06Sell5,000$30.610.65view
Popovits Kimberly JPresident and CEO 2016-12-05Sell5,000$30.022.63view
Leber LauraChief Communication Officer 2016-11-21Sell7,068$31.73-2.9view
Shak StevenChief Scientific Officer 2016-11-10Sell5,000$31.71-2.84view
Cole G BradleyCOO 2016-11-08Sell5,000$29.683.81view
Popovits Kimberly JPresident and CEO 2016-11-03Sell5,313$28.886.68view
Shak StevenChief Scientific Officer 2016-10-11Sell5,000$30.391.38view
Cole G BradleyCOO 2016-10-10Sell8,290$30.590.72view
Vaughn James JChief Commercial Officer 2016-10-06Sell3,000$29.683.81view
Shak StevenChief Scientific Officer 2016-09-13Sell5,000$26.8314.83view

Quarterly/Annual Reports about GHDX:

News about GHDX:

Articles On GuruFocus.com
Insiders Sell Alphabet, Facebook Aug 19 2016 
CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 

More From Other Websites
8:41 am Genomic Health announces results from multiple studies on Oncotype DX test in... Dec 09 2016
Genomic Health Announces Results from Multiple Oncotype DX® Studies, Reinforcing its Impact in... Dec 09 2016
Genomic Health: Cancer Test Business Strong, Q3 Dismal Dec 07 2016
Genomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : December 5, 2016 Dec 05 2016
Hedge Funds Begin to Sour on Kulicke and Soffa Industries Inc. (KLIC) Dec 02 2016
Genomic Health, Inc. breached its 50 day moving average in a Bearish Manner : GHDX-US : December 2,... Dec 02 2016
Genomic Health Announces Presentation of Multiple Oncotype DX® Studies at the 2016 CTRC-AACR San... Nov 29 2016
GENOMIC HEALTH INC Financials Nov 10 2016
GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report Nov 04 2016
Genomic Health, Inc. breached its 50 day moving average in a Bearish Manner : GHDX-US : November 3,... Nov 03 2016
Genomic Health to Present at the Credit Suisse 25th Annual Healthcare Conference Nov 03 2016
Genomic Health (GHDX) Posts Wider-than-Expected Q3 Loss Nov 02 2016
Edited Transcript of GHDX earnings conference call or presentation 1-Nov-16 8:30pm GMT Nov 01 2016
Genomic Health reports 3Q loss Nov 01 2016
Genomic Health reports 3Q loss Nov 01 2016
GENOMIC HEALTH INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Results of... Nov 01 2016
Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of... Nov 01 2016
Genomic Health Announces Positive Topline Clinical Validation Study Results Demonstrating Oncotype... Nov 01 2016
Q3 2016 Genomic Health Inc Earnings Release - After Market Close Nov 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)